W.R. Berkley’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
Other funds holding JSPR
LPARFS
W.R. Berkley's JSPR Position: Q3 2021 in Review
W.R. Berkley sold out of Jasper Therapeutics (JSPR) in Q3 2021, closing a stake of 1,460 shares — an estimated $4.35M sold.
W.R. Berkley first reported a position in JSPR in Q2 2021 and held it in 1 quarter. The position peaked at $4.35M in Q2 2021. 10 funds tracked by Wall St. Rank hold JSPR as of Q3 2021.
- W.R. Berkley reported no remaining Jasper Therapeutics position as of Q3 2021 after selling out during the quarter.
- W.R. Berkley sold 1,460 Jasper Therapeutics shares in Q3 2021, an estimated $4.35M.
- W.R. Berkley first reported a position in Jasper Therapeutics in Q2 2021 and held it in 1 quarter.
- W.R. Berkley's Jasper Therapeutics position peaked at $4.35M in Q2 2021.
- 10 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2021.
Based on W.R. Berkley's 13F filing for Q3 2021, filed 15 Nov 2021.